Filing Details

Accession Number:
0001179110-12-015782
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-07 16:31:40
Reporting Period:
2012-11-05
Filing Date:
2012-11-07
Accepted Time:
2012-11-07 16:31:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
815094 Abiomed Inc ABMD Surgical & Medical Instruments & Apparatus (3841) 042743260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203056 Gerald W Austen C/O Abiomed, Inc.
22 Cherry Hill Drive
Danvers MA 01923
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Disposition 2012-11-05 20,000 $13.26 70,200 No 4 S Indirect Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Footnote
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $10.06 2006-08-09 2015-08-10 8,000 8,000 Direct
Common Stock Stock Option (right to buy) $13.21 2007-08-08 2016-08-09 8,000 8,000 Direct
Common Stock Stock option (right to buy) $12.69 2008-08-13 2017-08-08 8,000 8,000 Direct
Common Stock Stock Option (right to buy) $18.63 2009-08-12 2018-08-13 12,000 12,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-08-10 8,000 8,000 Direct
2016-08-09 8,000 8,000 Direct
2017-08-08 8,000 8,000 Direct
2018-08-13 12,000 12,000 Direct
Footnotes
  1. This option becomes exercisable in full on the date set forth in Table II, Column 6.
  2. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
  3. Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
  4. Represents shares held by the W. Gerald Austen Rev Trust, of which the Reporting Person and his spouse are the Trustees and the Reporting Person's spouse and children are the beneficiaries. The Reporting Person disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of such shares for purposes of Section 16 or for any other purpose.
  5. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $13.02 and $13.73. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.